相关实验视频

Updated: Jun 14, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

瘤无关的癌症治疗,使用针对胎儿的冠状腺素硫酸盐的抗体

Elena Ethel Vidal-Calvo^1,2, Anne Martin-Salazar³, Swati Choudhary^3,4

¹Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. elena@sund.ku.dk.

Nature communications

|August 30, 2024

概括

研究人员发现了针对子宫内胆固醇硫酸盐 (ofCS) 的新型抗体片段,这是瘤中发现的胚胎特征. 这些碎片显示出开发新的癌症治疗和诊断的前景.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

恶性细胞与胚胎细胞具有分子相似性,具有独特的治疗点.
胎冠状素硫酸盐 (ofCS) 是一个由瘤表达的胚胎标记物,促进癌症的进展和转移.

研究的目的:

识别和表征抗体碎片,这些碎片专门针对子宫内冠状素硫酸盐 (ofCS).
在各种癌症模型中评估这些抗ofCS抗体碎片的治疗和诊断潜力.

主要方法:

体显示技术被用来发现针对不同ofCS表观的抗体片段.
在实验室和体内对各种固体瘤类型的结合亲和性和特异性进行了评估.
制造和测试了抗ofCS抗体药物合物和双特异性免疫细胞参与剂.

主要成果:

新型抗体碎片显示了高结合亲和力 (低纳米范围) 的ofCS.
这些碎片表现出对固体瘤的特定结合,与健康或良性组织的相互作用最小.
在临床前癌症模型中,治疗性结合物和参与者有效地扰乱了瘤的进展.

结论:

抗ofCS抗体碎片代表了针对性癌症治疗和诊断的有希望的工具.
这些发现支持基于ofCS向开发基于人类恶性瘤的广泛有效治疗方法.

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...